Chipscreen’s Epidaza Patent Faces Invalidation Request Review
China-based Shenzhen Chipscreen Biosciences Co., Ltd (SHA: 688321) has announced that a patent invalidation request...
Legal / IP
Novartis to Defend Entresto Patent After CAFC Ruling
Novartis (NYSE: NVS) has revealed a favorable decision by the US Court of Appeals for...
SynCardia’s Next-Generation Artificial Heart Granted Patent in China
US-based SynCardia Systems, LLC., a global leader in total artificial heart technology, has announced that...
Roche’s Evrysdi Receives Patent Term Extension in China, Extending Protection to 2035
The China National Intellectual Property Administration (CNIPA) has granted Swiss pharmaceutical giant Roche (SWX: ROG)...
BeiGene Reaches Patent Settlement with MSN Pharmaceuticals for Brukinsa
China-based BeiGene Ltd (NASDAQ: BGNE; HKG: 6160; SHA: 688235), which is in the process of...
Novo Nordisk Expands Legal Campaign to 50 Cases Against Semaglutide Compounders
Novo Nordisk (NYSE: NVO) has escalated its legal battles in the healthcare sector by filing...
China’s NMPA Proposes Rewards for Internal Whistleblowers in Drug and Medical Device Safety Reporting
The National Medical Products Administration (NMPA) of China has issued a draft proposal for the...
Oxford Nanopore Sets Sights on BGI in UK Courts Over Nanopore Sequencing Technology
Oxford Nanopore Technologies plc (LON: ONT), a UK-based leader in nanopore sequencing technology, has disclosed...
AbbVie Accuses BeiGene of Trade Secret Theft in BTK Degrader Dispute
AbbVie Sues BeiGene Over Alleged Trade Secret Theft in BTK Degrader ProgramU.S. pharmaceutical titan AbbVie...
US House Approves Biosecure Act with Implications for Chinese Biotech Firms
The US House of Representatives has taken a decisive step towards tightening biosecurity measures, voting...
AstraZeneca Faces Investigation in China Over Data Privacy and Unapproved Drugs
AstraZeneca (NASDAQ: AZN), a leading UK pharmaceutical company, is reportedly under the spotlight in Shenzhen,...
China’s Supreme Court Deals Blow to Sanofi’s Aubagio, Confirms Patent Cancellation
BEIJING—In a recent development for the pharmaceutical industry, Sanofi’s multiple sclerosis therapy Aubagio (teriflunomide) has...
Takeda’s Entyvio Receives Historic Patent Term Adjustment in China, a First for the Country
On August 16, a significant milestone was reached as the China National Intellectual Property Administration...
Peking Union Medical College Innovates with Angle Positioning Device Patent Sale
Peking Union Medical College Hospital (PUMCH) has announced its intention to transfer the patent for...
Astellas Pharma Employee in China Formally Indicted on Espionage Suspicion
Astellas Pharma Inc., a Japanese pharmaceutical company listed on the Tokyo Stock Exchange (TYO: 4503),...
Novartis Intensifies Legal Action Against FDA Over Entresto Generic Approval
Novartis Inc. (NYSE: NVS) is intensifying its efforts to thwart the entry of generic competitors...
HuidaGene Secures Patent for Innovative CRISPR-Cas12i System in China
HuidaGene (Shanghai) Biotechnology Co., Ltd, a China-based biotech firm, has secured patent approval from the...
China’s SAMR Proposes Antitrust Guidelines to Regulate Pharmaceutical Industry
The State Administration for Market Regulation (SAMR) in China has unveiled a draft proposal for...
Pfizer, Astellas, and University of California Sue Qilu Pharma Over Xtandi Patent Infringement
Pfizer Inc. (NYSE: PFE), through its subsidiary Medivation, and co-development partner Astellas Pharma Inc. (TYO:...
Sirnaomics Ltd Forms JV with Gore Range Capital to Pioneer Medical Aesthetics Innovations
Sirnaomics Ltd (HKG: 2257), a biopharmaceutical company specializing in RNAi therapeutics, has announced the formation...